Skip to main content
. 2015 Sep 27;6(32):34023–34029. doi: 10.18632/oncotarget.5850

Table 3. Genotype distributions, odds ratios (OR) and 95% confidence intervals (CI) for the association between breast cancer susceptibility loci of FGFR3 and FGFR4 in 747 breast cancer cases and 716 controls.

Genotype Case (n=747) Control (n=716) OR (95%CI) P OR (95%CI)a Pa
rs1966265
AA 168 (22.5) 226 (31.6) 1.000 1.000
AG 408 (54.6) 364 (50.8) 1.508 (1.181-1.926) 0.001 1.581 (1.232-2.028) 3*10−4
GG 171 (22.9) 126 (17.6) 1.826 (1.346-2.476) 1*10-4 1.890 (1.387-2.576) 5*10−5
G allele 750 (50.2) 616 (43.0) 1.335 (1.154-1.545) 1*10-4 1.360 (1.173-1.577) 5*10−5
AG+GG 579 (77.5) 490 (68.4) 1.590 (1.259-2.007) 9*10-5 1.661 (1.310-2.106) 3*10−5
rs351855
GG 205 (27.4) 270 (37.7) 1.000 1.000
GA 404 (54.1) 348 (48.6) 1.529 (1.213-1.927) 3*10-4 1.555 (1.230-1.967) 2*10−4
AA 138 (18.5) 98 (13.7) 1.855 (1.352-2.544) 1*10-4 1.899 (1.377-2.617) 8*10−5
A allele 680 (45.5) 544 (38.0) 1.364 (1.177-1.580) 4*10-5 1.382 (1.190-1.605) 2*10−5
GA+AA 542 (72.6) 446 (62.3) 1.601 (1.284-1.996) 3*10-5 1.631 (1.303-2.040) 2*10−5
rs2234909
TT 672 (90.0) 638 (89.1) 1.000 1.000
TC 71 (9.5) 77 (10.8) 0.875 (0.623-1.230) 0.443 0.903 (0.639-1.276) 0.563
CC 4 (0.5) 1 (0.1) 3.798 (0.423-34.068) 0.233 3.884 (0.427-35.290) 0.228
C allele 79 (5.3) 79 (5.5) 0.956 (.694-1.318) 0.784 0.985 (.712-1.364) 0.929
TC+CC 75 (10.0) 78 (10.9) 0.913 (0.653-1.276) 0.594 0.942 (0.670-1.324) 0.731
rs3135848
TT 576 (77.1) 553 (77.2) 1.000 1.000
TC 157 (21.0) 155 (21.6) 0.972 (0.757-1.250) 0.827 0.971 (0.753-1.252) 0.821
CC 14 (1.9) 8 (1.1) 1.680 (0.699-4.036) 0.246 1.619 (0.658-3.981) 0.294
C allele 185 (12.4) 171 (11.9) 1.042 (.835-1.301) 0.715 1.035 (.826-1.296) 0.767
TC+CC 171 (22.9) 163 (22.8) 1.007 (0.789-1.286) 0.954 1.002 (0.782-1.284) 0.985
a

Adjusted for age, BMI, age at menarche and menopausal status.